Molecular pathogenesis of non-Hodgkin lymphoma: A clinical perspective

G. Gaidano, C. Pastore, G. Volpe

Risultato della ricerca: Contributo su rivistaArticolo di reviewpeer review

Abstract

Despite a common origin from mature lymphoid cells, non-Hodgkin lymphomas (NHL) represent a surprisingly heterogeneous group of lymphoid malignancies whose classification is continuously being remodeled. The most recent proposal, the Revised European-American classification, introduces pathogenetic features among the classification criteria. In this respect, knowledge of the molecular pathogenesis of NHL, which is based upon genetic lesions leading to activation of protooncogenes (e.g. BCL-1, BCL-2, BCL-6, c-MYC) or disruption of tumor suppressor genes (e.g. p53), is becoming increasingly relevant for the clinician. These lesions combine into multiple molecular pathways which are selectively associated with distinct NHL types. Thus, for example, rearrangements of BCL-1, BCL-2, BCL-6, and c-MYC are the genetic hallmarks of mantle cell, follicular, diffuse large cell, and Burkitt's lymphoma, respectively. Overall, from a clinical perspective, NHL genetic lesions serve three purposes: a) they assist and complement histologic diagnosis; b) they provide a molecular marker with prognostic relevance; c) they allow evaluation of minimal residual disease through highly specific and highly sensitive technologies.

Lingua originaleInglese
pagine (da-a)454-472
Numero di pagine19
RivistaHaematologica
Volume80
Numero di pubblicazione5
Stato di pubblicazionePubblicato - 1995
Pubblicato esternamente

Fingerprint

Entra nei temi di ricerca di 'Molecular pathogenesis of non-Hodgkin lymphoma: A clinical perspective'. Insieme formano una fingerprint unica.

Cita questo